| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 46.49M | 48.12M | 49.91M | 52.17M | 53.48M | 51.22M |
| Gross Profit | 29.62M | 30.95M | 29.33M | 31.71M | 31.78M | 30.33M |
| EBITDA | -2.34M | -1.80M | -5.76M | -4.03M | 1.85M | -36.66M |
| Net Income | -4.83M | -4.95M | -9.91M | -8.24M | -4.39M | -38.45M |
Balance Sheet | ||||||
| Total Assets | 41.15M | 43.20M | 47.48M | 56.79M | 65.83M | 76.93M |
| Cash, Cash Equivalents and Short-Term Investments | 10.32M | 12.77M | 14.61M | 20.47M | 27.09M | 33.85M |
| Total Debt | 802.00K | 1.22M | 2.10M | 1.64M | 3.26M | 10.09M |
| Total Liabilities | 9.20M | 10.57M | 11.61M | 12.68M | 14.32M | 24.24M |
| Stockholders Equity | 31.94M | 32.63M | 35.87M | 44.11M | 51.50M | 52.69M |
Cash Flow | ||||||
| Free Cash Flow | -850.00K | -1.53M | -5.77M | -5.16M | -7.69M | -4.73M |
| Operating Cash Flow | -654.00K | -1.10M | -4.39M | -2.29M | -6.34M | -3.37M |
| Investing Cash Flow | -1.06M | -429.00K | -1.31M | -2.87M | -951.00K | 981.00K |
| Financing Cash Flow | -46.00K | -307.00K | -160.00K | -1.46M | 528.00K | -5.49M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
55 Neutral | $72.88M | -15.14 | -14.61% | ― | -4.32% | -13.99% | |
48 Neutral | $40.46M | -8.75 | -38.21% | ― | 25.10% | 50.62% | |
47 Neutral | $23.80M | -4.46 | -26.62% | ― | -11.07% | 82.06% | |
41 Neutral | $3.01M | -0.05 | ― | ― | -62.46% | -12.90% | |
38 Underperform | $60.58M | -1.82 | -127.41% | ― | -18.94% | 37.05% |
On December 16, 2025, Marchex held its annual meeting of stockholders, during which all directors were re-elected and an independent registered public accounting firm was ratified. Following the meeting, Marchex’s Compensation Committee approved stock option grants for its directors as part of their annual board service, with a total of 50,000 options issued to each director under the 2021 Stock Incentive Plan. Directors will also receive quarterly cash compensation, aiming to strengthen corporate governance and align leadership incentives. These strategic decisions reflect the company’s efforts to foster stability in its board of directors while maintaining transparency for stakeholders.
On November 13, 2025, Marchex announced an agreement in principle to acquire Archenia, Inc., a performance-based customer qualification company, for $10 million in convertible promissory notes. This acquisition aims to create a vertically focused, AI-driven customer acquisition platform, potentially enhancing Marchex’s revenue scale, market reach, and strategic flexibility. Additionally, Marchex reported its third-quarter 2025 financial results, highlighting a decrease in GAAP revenue to $11.5 million compared to the previous year, but an improvement in adjusted EBITDA to $1.1 million. The company is optimistic about its future growth prospects, anticipating a 10% revenue growth in 2026 due to its ongoing product launches and technology platform migration.